I-Mab Signs Agreement to Divest its Assets and Business Operations in China
- Written by PR Newswire
 |
- Agreement marks an important milestone to advance the Company's intent to become a U.S.-based biotech
- Agreement provides for a strategic focus in advancing I-Mab's potential of differentiated oncology clinical assets and builds shareholder value by streamlining the operating model, reducing operational costs, and mitigating potential...
